These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Kakumoto M, Sakaeda T, Takara K, Nakamura T, Kita T, Yagami T, Kobayashi H, Okamura N, Okumura K. Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479 [Abstract] [Full Text] [Related]
3. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Katoh M, Nakajima M, Yamazaki H, Yokoi T. Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223 [Abstract] [Full Text] [Related]
4. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. Takara K, Sakaeda T, Kakumoto M, Tanigawara Y, Kobayashi H, Okumura K, Ohnishi N, Yokoyama T. Oncol Res; 2009 Oct; 17(11-12):527-33. PubMed ID: 19806783 [Abstract] [Full Text] [Related]
5. Interaction of digoxin with antihypertensive drugs via MDR1. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K. Life Sci; 2002 Feb 15; 70(13):1491-500. PubMed ID: 11895100 [Abstract] [Full Text] [Related]
6. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog. De Rosa MF, Ackerley C, Wang B, Ito S, Clarke DM, Lingwood C. J Biol Chem; 2008 Feb 22; 283(8):4501-11. PubMed ID: 18003606 [Abstract] [Full Text] [Related]
7. Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Takara K, Tsujimoto M, Ohnishi N, Yokoyama T. Biochem Biophys Res Commun; 2002 Mar 22; 292(1):190-4. PubMed ID: 11890691 [Abstract] [Full Text] [Related]
8. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF. J Pharmacol Exp Ther; 2000 May 22; 293(2):376-82. PubMed ID: 10773005 [Abstract] [Full Text] [Related]
9. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Hirsch-Ernst KI, Ziemann C, Rustenbeck I, Kahl GF. Toxicology; 2001 Oct 05; 167(1):47-57. PubMed ID: 11557129 [Abstract] [Full Text] [Related]
10. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Abe T, Koike K, Ohga T, Kubo T, Wada M, Kohno K, Mori T, Hidaka K, Kuwano M. Br J Cancer; 1995 Aug 05; 72(2):418-23. PubMed ID: 7640227 [Abstract] [Full Text] [Related]
11. Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells. Iida N, Takara K, Ohmoto N, Nakamura T, Kimura T, Wada A, Hirai M, Sakaeda T, Okumura K. Biol Pharm Bull; 2001 Sep 05; 24(9):1032-6. PubMed ID: 11558564 [Abstract] [Full Text] [Related]
12. Interaction of docetaxel ("Taxotere") with human P-glycoprotein. Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K. Jpn J Cancer Res; 1999 Dec 05; 90(12):1380-6. PubMed ID: 10665657 [Abstract] [Full Text] [Related]
13. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs. Kakumoto M, Takara K, Sakaeda T, Tanigawara Y, Kita T, Okumura K. Biol Pharm Bull; 2002 Dec 05; 25(12):1604-7. PubMed ID: 12499648 [Abstract] [Full Text] [Related]
14. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines. Takara K, Sakaeda T, Yagami T, Kobayashi H, Ohmoto N, Horinouchi M, Nishiguchi K, Okumura K. Biol Pharm Bull; 2002 Jun 05; 25(6):771-8. PubMed ID: 12081145 [Abstract] [Full Text] [Related]
15. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y. Breast Cancer Res; 2001 Jun 05; 3(4):253-63. PubMed ID: 11434876 [Abstract] [Full Text] [Related]
16. Simvastatin and lovastatin, but not pravastatin, interact with MDR1. Sakaeda T, Takara K, Kakumoto M, Ohmoto N, Nakamura T, Iwaki K, Tanigawara Y, Okumura K. J Pharm Pharmacol; 2002 Mar 05; 54(3):419-23. PubMed ID: 11902809 [Abstract] [Full Text] [Related]
17. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME, Podila L, Ely D, Almeida I. Drug Metab Dispos; 2005 Nov 05; 33(11):1679-87. PubMed ID: 16093365 [Abstract] [Full Text] [Related]
18. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein. Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K. J Pharm Pharmacol; 2006 Dec 05; 58(12):1617-22. PubMed ID: 17331325 [Abstract] [Full Text] [Related]
19. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line. Massart C, Gibassier J, Raoul M, Pourquier P, Leclech G, Robert J, Lucas C. Anticancer Drugs; 1995 Feb 05; 6(1):135-46. PubMed ID: 7756676 [Abstract] [Full Text] [Related]
20. Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells. Itagaki F, Homma M, Takara K, Ohnishi N, Yokoyama T, Sakaeda T, Yagami T, Kobayashi H, Okamura N, Kohda Y. Biol Pharm Bull; 2004 Oct 05; 27(10):1694-6. PubMed ID: 15467223 [Abstract] [Full Text] [Related] Page: [Next] [New Search]